LIVONIA, Mich., July 01, 2025 (GLOBE NEWSWIRE) — A new Cogent Syndicated report from Escalent finds that, for the first time since 2021, midyear utility Brand Trust has improved. As utilities work to strengthen their reputations and sharpen their communication efforts, the industry's Brand Trust Index has risen 17 points, reaching 697 on a 1,000-point […]
(NASDAQ:SVRA), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Savara Inc. (“Savara” or the “Company”) (NASDAQ: SVRA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Savara and certain of its officers and/or directors have engaged
GENEVA, Ill., July 01, 2025 (GLOBE NEWSWIRE) — Iteris, Inc., the world's trusted technology ecosystem for smart mobility infrastructure management and part of Almaviva Group, today announced that it has been awarded a three-year contract renewal by the Kane County Division of Transportation (Kane County DOT) to support a comprehensive smart mobility, safety and sustainability
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — TransPerfect, the world's largest provider of language and AI solutions for global business, today announced that its TransPerfect Media division, specializing in audiovisual post-production and localization services, supported four award-winning films at the 2025 Cannes Film Festival. TransPerfect Media and its recently acquired studio MPC Paris provided
(NASDAQ:SMLR), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Semler and certain of its officers and/or directors have
(NASDAQ:ABL), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Abacus and certain of its officers and/or directors
(NASDAQ:HNRG), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Hallador Energy Company (“Hallador” or the “Company”) (NASDAQ: HNRG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Hallador and certain of its officers and/or directors have
(NYSE:BF-B),(NYSE:BF-A), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Brown-Forman Corporation (“Brown-Forman” or the “Company”) (NYSE: BF-B; BF-A). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Brown-Forman and certain of its officers and/or directors have
(NasdaqGM:SMMT), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Summit Therapeutics Inc. (“Summit” or the “Company”) (NASDAQ: SMMT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Summit and certain of its officers and/or directors have
(NasdaqGM:NPCE), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of NeuroPace, Inc. (“NeuroPace” or the “Company”) (NASDAQ: NPCE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether NeuroPace and certain of its officers and/or directors have engaged